Live Breaking News & Updates on Edars sinai cancer multiple myeloma protein ephrin b2 unique signaling pathway journal research therapies to target cells bone marrow endothelial eph receptors reverse signal drives mm joshua sasine cedars hematologist oncologist fundamental biological insights john chute division of hematology and cellular therapy at regulating progression expression novel therapeutic intractable national institutes health tower foundation asco young investigator award

Stay updated with breaking news from Edars sinai cancer multiple myeloma protein ephrin b2 unique signaling pathway journal research therapies to target cells bone marrow endothelial eph receptors reverse signal drives mm joshua sasine cedars hematologist oncologist fundamental biological insights john chute division of hematology and cellular therapy at regulating progression expression novel therapeutic intractable national institutes health tower foundation asco young investigator award. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

RESEARCH ALERT: Stopping Multiple Myeloma

Cedars-Sinai Cancer investigators have discovered a protein expressed on multiple myeloma cancer cells that drives disease growth and development. The new study

Joshua-sasine , Cancer-research , Division-of-hematology , Sinai-cancer , John-chute , Cellular-therapy , Cedars-sinai-cancer , Newswise , Edars-sinai-cancer-multiple-myeloma-protein-ephrin-b2-unique-signaling-pathway-journal-research-therapies-to-target-cells-bone-marrow-endothelial-eph-receptors-reverse-signal-drives-mm-joshua-sasine-cedars-hematologist-oncologist-fundamental-biological-insights-john-chute-division-of-hematology-and-cellular-therapy-at-regulating-progression-expression-novel-therapeutic-intractable-national-institutes-health-tower-foundation-asco-young-investigator-award , Edars-sinai ,